The Effects of Long-Term Hemodialysis on Gastrointestinal Function

  • Joseph J. Ricca
  • George J. Rezk
  • Robert P. Yatto


Numerous studies indicate the prominence of gastrointestinal disturbance in uremia; however, to our knowledge there are no reports comparing the effects of a decade or longer of hemodialysis versus short-term hemodialysis on gastrointestinal function. Previous reports have shown that patients on maintenance hemodialysis have an increased incidence of hiatus hernia and diverticulosis coli,1 as well as gastrointestinal hemorrhage from a variety of lesions, including gastritis, duodenitis, and peptic ulcer disease.2–4 Ascites is occasionally seen and is often of uncertain origins5,6 An increased incidence of pancreatitis has been found postmortem.’ Enzymatic evidence of hepatic malfunction,8–10 as well as alterations in serum gastrin11,12 and serum amylase,13 have also been described.


Chronic Renal Failure Serum Gastrin Gastrin Level Alkaline Phosphatase Level Gamma Glutamyl Transpeptidase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bailey GI, Griffiths H, Locke JP, et al: Gastrointestinal abnormalities in uremia. Am Soc Nephrol5: 5, 1971.Google Scholar
  2. 2.
    Boner G, Berry EM: Gastrointestinal hemorrhage complicating chronic hemodialysis. Isr J Sci 4: 66, 1968.Google Scholar
  3. 3.
    Shepherd AMM, Stewart WK, Wormsely KG: Peptic ulceration in chronic renal failure. Lancet 1: 1357, 1973.PubMedCrossRefGoogle Scholar
  4. 4.
    Margolus DM, Saylor JL, Geisse G, et al: Upper gastrointestinal disease in chronic renal failure: A prospective evaluation. Arch Intern Med 138: 1214, 1978.CrossRefGoogle Scholar
  5. 5.
    Eknoyan G, Dichoso C, Hyde S, et al: "Overflow ascites"-The safety valve of the volume expanded patient on dialysis. Proc Clin Dial Transpl Forum 3: 156, 1973.Google Scholar
  6. 6.
    Gotloib L, Servadio C: Ascites in patients undergoing maintenance dialysis. Am J Med 61: 465, 1976.PubMedCrossRefGoogle Scholar
  7. 7.
    Avram MM: High prevalence of pancreatic disease in chronic renal failure. Nephron 18: 68, 1977.PubMedCrossRefGoogle Scholar
  8. 8.
    Bailey GL, Katz AI, Hampers CL, et al: Alterations in serum enzymes in chronic renal failure. JAMA 213: 2263, 1970.PubMedCrossRefGoogle Scholar
  9. 9.
    Crawford DR, Reyna RS, Weiner MW: Effects of in vivo and in vitro dialysis on plasma transaminase activity. Nephron 22: 418, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    Cohen GA, Goffinet JA, Donabedian RK, et al: Observations on decreased serum glutamic oxalacetic transaminase (SCOT) activity in azotemic patients. Ann Int Med 84: 275, 1976.PubMedGoogle Scholar
  11. 11.
    Reeder DD, Thompson JC: Effect of hemodialysis on serum gastrin levels in uremic patients. Gastroenterology 60: 795, 1971.Google Scholar
  12. 12.
    Korman MG, Laver MC, Hansky J: Hypergastrinemia in chronic renal failure. Brit Med J 1: 209, 1972.PubMedCrossRefGoogle Scholar
  13. 13.
    Berk JE, Fridhandler L, Ness RL: Amylase and isoamylase activities in renal insufficiency. Ann Int Med 90: 351, 1979.PubMedGoogle Scholar
  14. 14.
    Dorph S, Oigaard A, Pederson G: Gastroduodenal mucosal changes in chronic uremia. Scand J Gastroent 7: 589, 1972.PubMedCrossRefGoogle Scholar
  15. 15.
    Jaffe RH, Laing DR: Changes of the digestive tract in uremia: A pathologic anatomic study. Arch Intern Med 53: 851, 1934.CrossRefGoogle Scholar
  16. 16.
    Hampers CI„ Schupak E, Lowrie EF: The gastrointestinal system, in Hampers CL, Schupak E, Lowriie EF, et al (eds): Long Term Hemodialysis. New York, Grune & Stratton, 1974, p 136.Google Scholar
  17. 17.
    Sengar DPS, Rashid A, McLeish WA, et al: Hepatitis B surface antigen infection in a hemodialysis unit. CMA J 113: 945, 1975.Google Scholar
  18. 18.
    Snydman DR: Hemodialysis associated hepatitis in the United States-1972. CDS News 109.Google Scholar
  19. 19.
    Posen S: Alkaline phosphatase. Ann Intern Med 67: 183, 1967.PubMedGoogle Scholar
  20. 20.
    Nagant de Deuxchaisnes C, Krane SM: Paget’s disease of bone: Clinical and metabolic observations. Medicine 43: 233, 1964.Google Scholar
  21. 21.
    Dent CE, Harper CM: Plasma alkaline phosphatase in normal adults and in patients with primary hyperparathyroidism. Lancet 1: 599, 1962.Google Scholar
  22. 22.
    Robinson JC, Pierce JE, Blumberg BS: The serum alkaline phosphatase of pregnancy. Am J Obstet Gynec 94: 559, 1966.PubMedGoogle Scholar
  23. 23.
    Heino AE, Jokipii SG: Serum alkaline phosphatase levels in the aged. Ann Med Intern Tenn 51: 105, 1962.Google Scholar
  24. 24.
    Clark LC, Beck E: Plasma alkaline phosphatase activity. J Pediat 36: 335, 1950.PubMedCrossRefGoogle Scholar
  25. 25.
    Kaplan MM, Righetti A: Induction of rat liver alkaline phosphatase: The mechanism of the serum elevation in bile duct obstruction. J Clin Invest 49: 508, 1970.PubMedCrossRefGoogle Scholar
  26. 26.
    Kaplan MM: Alkaline phosphatase. Gastroenterology 62: 452, 1972.PubMedGoogle Scholar
  27. 27.
    Breeensilver HL, Kaplan MM: Significance of elevated liver alkaline phosphatase in serum. Gastroenterology 68: 1556, 1975.Google Scholar
  28. 28.
    Kaplan MM: in Davidson CS (ed): Problems in Liver Disease. New York, Stratton Intercontinental Medical Book Corp, 1979, p 79.Google Scholar
  29. 29.
    Goldberg JA, Pineda EP, et al: A method for the colorimetric determination of gamma glutamyl transpeptidase in human serum; enzymatic activity in health and disease. Gastroenterology 44: 127, 1963.Google Scholar
  30. 30.
    Orlowski M: Role of gamma glutamyl transpeptidase in the internal diseases. Clin Arch Immunol Ther Exp 1: 11, 1963.Google Scholar
  31. 31.
    Zein M, Discombe G: Serum gamma glutamyl transpeptidase as a diagnostic aid. Lancet 2: 748, 1970.PubMedCrossRefGoogle Scholar
  32. 32.
    Levinson M, Holbert J, Blackwell C, et al: Serum gamma glutamyl transpeptidase: Its specificity and clinical value. S Med J 72: 837, 1979.CrossRefGoogle Scholar
  33. 33.
    Dragosics B, Ferenci P, Pesendorfer F, et al: Gamma glutamyl transpeptidase: Its relationship to other enzymes for diagnosis of liver disease, in Popper CF (ed): Progress in Liver Diseases. New York, Grune & Stratton, Vol. 5, 1976, p 436.Google Scholar
  34. 34.
    Christensen CK, Nielsen HE, Kamstrup KJ, et al: Serum gastrin and serum calcitonin in patients with chronic renal failure. ACTA Endocrin 91: 564, 1971.Google Scholar
  35. 35.
    Owyang C, Miller LJ, DiMagno EP, et al: Gastrointestinal hormone profile in renal insufficiency. Mayo Clin Proc 54: 769, 1979.PubMedGoogle Scholar
  36. 36.
    Gokal R, Kefflewell M, Drexler E, et al: Gastrin levels in chronic renal failure, hemodialysis and renal transplant patients. Clin Nephrol 14: 96, 1980.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1982

Authors and Affiliations

  • Joseph J. Ricca
    • 1
    • 2
  • George J. Rezk
    • 3
  • Robert P. Yatto
    • 3
  1. 1.Division of GastroenterologyThe Long Island HospitalBrooklynUSA
  2. 2.Department of MedicineThe Long Island College HospitalBrooklynUSA
  3. 3.Division of GastroenterologyThe Long Island College HospitalBrooklynUSA

Personalised recommendations